Irinoteman is a chemotherapy drug whose active ingredient is irinoteman chloride.
It is an injectable drug, used exclusively by adults and intended to remove cancer cells from the body.
Colon cancer; Rectum cancer; Lung cancer Ovarian cancer Breast cancer.
Increased sweat; Saliva production diarrhea; Stomach pain; Nausea vomiting loss of appetite Low resistance to infections anemia hair loss fatigue Tear weakness.
Pregnant women; Women who breastfeed; people with hypersensitivity to the components of the irinoteman formula.
Injectable use
adults
The administered dose is usually 180 mg irinotean every 2 weeks, this dose may be adjusted by the doctor depending on the age, clinical condition and adverse effects manifested by the patient.
The medicine is applied to the vein for 30 to 90 minutes.